Other News

Tiara™ Featured in Presentation at 11th Annual TVT 2019

VANCOUVER, June 17, 2019 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that its Tiara™ (“Tiara”) transcatheter mitral valve replacement […]

CHF Solutions Sponsored AATS Session on Post-Cardiac Surgery, Highlighting Benefits of Using the Aquadex FlexFlow® System Following Cardiac Surgery

EDEN PRAIRIE, Minn., June 13, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), today announced highlights from the sponsored session from the American Association for Thoracic SurgeryAnnual Meeting moderated by Daniel Beckles, M.D., Ph.D. of United Health Services Hospitals in Binghamton, N.Y. The full session can be found on the company’s website at www.chf-solutions.com. The panel, titled “Personalized Medicine: […]

Surgical Theater’s Precision VR® featured during Late-Breaking Science Sessions at the Transcatheter Valve Therapies 2019 Structural Heart Summit

CHICAGO, June 13, 2019 /PRNewswire/ — Leveraging its rich history of providing surgeons and their patients dynamic visualization experiences in the clinic and throughout the treatment continuum, Surgical Theater is proud that the Precision VR® platform is being  featured  at the Transcatheter Valve Therapies (TVT) Structural Heart Summit’s Late-Breaking Science Sessions in Chicago, IL. […]

Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite

CHICAGO–(BUSINESS WIRE)–TVT2019 – Structural Heart Summit — Materialise (NASDAQ:MTLS), a global 3D printing software and solutions company, has received FDA clearance for its Mimics Enlight cardiovascular planning software suite. The first release will support clinicians planning complex transcatheter mitral valve replacement (TMVR) procedures. Mimics Enlight is based on the strengths of […]

New Data Shows The Carillon Mitral Contour System® Is Associated With Improvement In Regurgitant Volume In Patients With Increased Mitral Valve Tenting

CHICAGO, June 13, 2019 /PRNewswire/ — Cardiac Dimensions, a leader in the development of minimally invasive treatments for functional mitral regurgitation (FMR) in patients with heart failure, presented data at the TVT2019 Structural Heart Summit showing increased mitral valve tenting is associated with an improvement in regurgitant volume with the Carillon Mitral Contour […]

Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed’s Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership

TOKYO, June 13, 2019 /PRNewswire/ — Terumo Corporation (TSE: 4543), a leading global medical device manufacturer, today announced that it has secured exclusive global development and commercialization rights to Virtue® Sirolimus-Eluting Balloon (SEB) for percutaneous coronary interventions by entering into a strategic partnership with Orchestra BioMed, Inc., a biomedical innovation company providing high-impact solutions […]

TCAR Achieves Favorable Outcomes vs. Carotid Endarterectomy in Patients with Carotid Artery Disease

Updated Results of TCAR Surveillance Project Presented at Society for Vascular Surgery Vascular Annual Meeting NATIONAL HARBOR, Md., June 13, 2019 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the presentation of real-world data for the […]

Cardiovascular Systems, Inc. Announces First Patient Enrolled in REACH PVI Clinical Study

ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the first patient was enrolled in the REACH PVI study. The purpose of this study is to prospectively evaluate acute […]